慢性病毒性肝炎B,C和D的当前治疗方法
1Department of Internal Medicine, Ameos Hospital Oberhausen, Wilhelmstr. 34, 46145 Oberhausen, Germany.
Journal of personalized medicine
|June 28, 2023
概括
慢性病毒性肝炎 (B,C和D型肝炎) 带来肝病和癌症的风险. 目前的乙型肝炎和乙型肝炎的治疗方法是有效的,但对于乙型肝炎需要新的策略,并实现乙型肝炎的功能治愈.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 慢性病毒性肝炎主要是由B型肝炎病毒 (HBV),C型肝炎病毒 (HCV) 和D型肝炎病毒 (HDV) 引起的,可显著增加肝硬化和肝细胞癌 (HCC) 的风险.
- 虽然目前的核酸/核酸类似物有效控制HBV感染并预防肝硬化,但实现功能治愈 (HBsAg损失) 仍然具有挑战性.
- 直接作用抗病毒药物 (DAA) 改变了HCV疗法,提供高治愈率,副作用最小.
研究的目的:
- 审查慢性HBV,HCV和HDV感染的当前和新兴治疗策略.
- 突出现有治疗方法的局限性和需要新的方法,特别是HBV功能治愈和HDV管理.
主要方法:
- 对慢性病毒性肝炎的当前和试验性治疗方法的文献综述.
- 对治疗结果的分析,包括病毒抑制,纤维化回归和功能治愈率.
- 讨论结合抗病毒疗法与免疫刺激以提高疗效的新策略.
主要成果:
- 乙型肝炎病毒感染可以用现有的抗病毒药物治疗,预防肝硬化,但功能性治愈很少见.
- DAA为HCV提供了高效且耐受性良好的治疗方法,从而导致几乎普遍的治愈.
- 肝炎D病毒 (HDV) 感染仍然难以治疗,与HBV和HCV相比,新型疗法显示的响应率不那么有利.
结论:
- 慢性病毒性肝炎的新型治疗策略侧重于实现功能性治疗,特别是针对HBV,通过向HBsAg抑制与免疫刺激相结合.
- 虽然HCV在很大程度上可以用DAA治疗,但HDV带来了持续的治疗挑战,需要进一步的研究和开发.
- 综合治疗方法对于管理与慢性病毒性肝炎相关的长期风险至关重要,包括肝病进展和HCC.
关键词:
在DAA治疗中使用DAA.导致HBsAg的损失.抗病毒疗法是一种抗病毒疗法.慢性乙型肝炎 慢性乙型肝炎慢性型肝炎 C 的病例.慢性乙型肝炎 D 型肝炎功能性治疗 治疗 治疗肝硬化是肝硬化的一种疾病.更多相关视频
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.3K
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
3.0K
相关概念视频
Retrovirus Life Cycles
46.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.2K
Diseases of the Liver and Gallbladder
674
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
674
Myocarditis III: Medical Management
9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Microorganisms in Medicine and Therapeutics
68
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
68
Chronic Pancreatitis II: Collaborative Care
116
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
116
Viruses with RNA Genomes
58
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
58
